Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing innovative, protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. The company's proprietary scientific platform uses a process known as directed evo... Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing innovative, protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. The company's proprietary scientific platform uses a process known as directed evolution to create therapeutics capable of modulating human immune system proteins. Its product pipeline includes ALPN-101 and ALPN-202. Mehr anzeigen
WINTER PARK, Fla., Nov. 19, 2024 (GLOBE NEWSWIRE) -- CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) announced today that its Board of Directors has authorized, and the Company has...
WINTER PARK, Fla., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company” or “PINE”) today announced that Jeffrey S. Yarckin has notified the Company of...
WINTER PARK, Fla., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company” or “PINE”), an owner and operator of single tenant net leased commercial...
WINTER PARK, Fla., Nov. 07, 2024 (GLOBE NEWSWIRE) -- CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) today announced the origination of a $40.2 million first mortgage loan with an...
WINTER PARK, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) today announced its operating results and earnings for the quarter ended...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.27 | 1.53148043108 | 17.63 | 18.44 | 17.36 | 54185 | 17.65681079 | CS |
| 4 | -0.37 | -2.02517788725 | 18.27 | 18.5 | 17.36 | 73596 | 17.83325405 | CS |
| 12 | -0.95 | -5.03978779841 | 18.85 | 19.42 | 17.12 | 91368 | 18.05664703 | CS |
| 26 | 2.08 | 13.1479140329 | 15.82 | 19.42 | 14.76 | 64013 | 17.44605306 | CS |
| 52 | 2.07 | 13.0764371447 | 15.83 | 19.42 | 14.325 | 59390 | 16.73389413 | CS |
| 156 | -0.17 | -0.940785832872 | 18.07 | 21.069 | 14.25 | 68495 | 17.34695267 | CS |
| 260 | -1.1 | -5.78947368421 | 19 | 21.069 | 7.56 | 68856 | 17.11270512 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
